Cenix Continues AstraZeneca Partnership | GenomeWeb

NEW YORK (GenomeWeb News) – Cenix Bioscience will conduct a new research project with AstraZeneca Pharmaceuticals focused on using cell-based studies to validate cancer drug targets, Dresden, Germany-based Cenix said today.

The project is the second between Cenix and Astrazeneca, and it will be conducted under the framework of the existing agreement between the companies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.